北京大学学报(医学版) ›› 2022, Vol. 54 ›› Issue (1): 48-53. doi: 10.19723/j.issn.1671-167X.2022.01.008

• 论著 • 上一篇    下一篇

伴与不伴糖尿病的牙周炎患者牙周基础治疗的疗效比较及其与白细胞水平的相关分析

徐欣然,霍芃呈,和璐(),孟焕新,朱筠轩,靳东思奇   

  1. 北京大学口腔医学院·口腔医院牙周科,国家口腔医学中心,国家口腔疾病临床医学研究中心,口腔数字化医疗技术和材料国家工程实验室,口腔数字医学北京市重点实验室,北京 100081
  • 收稿日期:2021-10-10 出版日期:2022-02-18 发布日期:2022-02-21
  • 通讯作者: 和璐 E-mail:helubj@tom.com

Comparison of initial periodontal therapy and its correlation with white blood cell level in periodontitis patients with or without diabetes mellitus

XU Xin-ran,HUO Peng-cheng,HE Lu(),MENG Huan-xin,ZHU Yun-xuan,JIN Dong-si-qi   

  1. Department of Periodontology, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China
  • Received:2021-10-10 Online:2022-02-18 Published:2022-02-21
  • Contact: Lu HE E-mail:helubj@tom.com

摘要:

目的: 比较伴与不伴糖尿病的牙周炎患者牙周基础治疗的临床疗效差异,并分析两组患者牙周基础治疗与白细胞水平的相关性。方法: 纳入无系统性疾病的慢性牙周炎患者32例(CP组),伴2型糖尿病的慢性牙周炎患者27例(CP+DM组)。所有患者行全口牙周检查和空腹血液检查,记录患者入院时的数据作为基线资料,包括探诊深度(probing depth, PD)、附着丧失(attachment loss, AL)、出血指数(bleeding index, BI)、菌斑指数(plaque index, PLI)、白细胞(white blood cell, WBC)计数和空腹血糖(fasting blood glucose, FBG),CP+DM组额外记录糖化血红蛋白(hemoglobin A1c, HbA1c)。对所有患者进行牙周基础治疗,治疗后3个月和6个月时重复入院时的所有检查。比较两组治疗前后牙周临床指标及血液指标的变化差异,采用广义线性混合模型分析WBC与牙周临床指标及糖代谢指标的相关性。结果: 入院时两组患者的牙周炎症和破坏程度一致,但CP+DM组WBC水平显著高于CP组[(7.14±1.99)×109/L vs. (6.01±1.26)×10 9/L, P=0.01]。牙周基础治疗3个月及6个月后,两组患者的全口平均PD、AL、BI及PLI均显著低于入院时基线水平,且6个月时CP+DM组的PD比3个月时仍有进一步降低[(3.33±0.62) mm vs. (3.61±0.60) mm,P<0.05]。治疗后3个月和6个月相比,两组各项牙周指标之间差异无统计学意义。CP+DM组治疗后3个月和6个月的HbA1c水平均显著低于基线水平[(7.09±0.79)% vs. (7.64±1.16)%,P<0.05;(7.06±0.78)% vs. (7.64±1.16)%,P<0.05], 6个月时的FBG显著低于基线水平[(7.35±1.14) mmol/L vs. (8.40±1.43) mmol/L,P<0.05]。CP组的WBC水平在治疗后3个月时显著低于基线水平[(5.35±1.37)×10 9/L vs. (6.01±1.26)×10 9/L,P<0.05],CP+DM组的WBC水平在治疗后6个月时显著低于基线水平[(6.00±1.37)×109/L vs. (7.14±1.99)×10 9/L,P<0.05]。广义线性混合模型分析显示,WBC水平与PD及FBG呈一定程度正相关。结论: 牙周基础治疗均能有效改善伴与不伴2型糖尿病的慢性牙周炎患者的牙周状况,有利于糖尿病患者的血糖控制,但糖尿病患者的牙周指标及WBC水平对牙周基础治疗的反应慢于不伴糖尿病的患者,WBC在糖尿病与牙周炎的相互关联中有重要意义。

关键词: 牙周炎, 糖尿病, 2型, 牙科刮治术, 牙周指数

Abstract:

Objective: To compare the clinical efficacy of initial periodontal therapy in periodontitis patients with or without type 2 diabetes mellitus and its correlation with white blood cell counts. Methods: In this study, 32 chronic periodontitis patients without systemic disease (CP group) and 27 chronic periodontitis patients with type 2 diabetes mellitus (CP+DM group) were enrolled. At admission, all the patients went through periodontal examination and fasting blood examination(baseline). Probing depth (PD), attachment loss (AL), bleeding index (BI), plaque index (PLI), white blood cells (WBC) counts and fasting blood glucose (FBG) were recorded respectively, while hemoglobin A1c (HbA1c) was recorded only in CP+DM group. After that, initial periodontal therapy was performed. All the tests were repeated 3 and 6 months after treatment. The changes of periodontal clinical indexes and WBC levels were compared between the two groups before and after treatment, and the correlation between WBC and periodontal clinical indexes and glucose metabolism indexes were analyzed by generalized linear mixed model. Results: At baseline, the periodontal inflammation and destruction were similar in CP and CP+DM group, but the WBC level was significantly higher in CP+DM groups [(6.01±1.26)×109/L vs. (7.14±1.99)×10 9/L, P=0.01]. After 3 and 6 months of initial periodontal therapy, the mean PD, AL, BI, and PLI in CP+DM and CP groups were significantly lower than the baseline, and the PD in CP+DM group was further decreased by 6 months compared with 3 months [(3.33±0.62) mm vs. (3.61±0.60) mm, P<0.05]. However, none of these periodontal indexes showed significant difference between the two groups by 3 or 6 months. In CP+DM group, HbA1c at 3 months and 6 months were significantly lower than the baseline [(7.09±0.79)% vs. (7.64±1.16)%, P<0.05; (7.06±0.78)% vs. (7.64±1.16)%, P<0.05], and FBG was significantly lower than the baseline by 6 months [(7.35±1.14) mmol/L vs. (8.40±1.43) mmol/L, P<0.05]. The WBC level in CP group was significantly lower than the baseline level by 3 months [(5.35±1.37)×10 9/L vs. (6.01±1.26)×10 9/L, P<0.05], while that in CP+DM group was significantly lower than the baseline level by 6 months [(6.00±1.37)×10 9/L vs. (7.14±1.99)×10 9/L, P<0.05]. The analysis of genera-lized linear mixed model showed that WBC level was significantly positively correlated with PD and FBG (P<0.05). Conclusion: Initial periodontal therapy can effectively improve the periodontal clinical status of patients with or without type 2 diabetes mellitus, and have benefits on glycemic control in diabetic patients. However, the response of periodontal indexes and WBC level to initial therapy were relatively delayed in diabetic patients. WBC plays an important role in the correlation between diabetes mellitus and periodontitis.

Key words: Periodontitis, Diabetes mellitus, type 2, Dental scaling, Periodontal index

中图分类号: 

  • R781.4

表1

CP组和CP+DM组患者的一般情况及入院时临床特征"

Items CP group
(n=32)
CP+DM group
(n=27)
P
Age/years 47.16±5.35 54.22±7.87 <0.001
Male 13 (40.6) 18 (66.7) 0.046
BMI/(kg/m2) 23.48±2.11 24.25±2.26 0.182
WHR 0.88±0.06 0.88±0.03 0.614
PD/mm 4.68±0.59 4.63±0.95 0.821
AL/mm 4.43±1.20 4.56±0.99 0.669
BI 3.20±0.63 2.90±0.73 0.089
PLI 2.97±0.12 2.85±0.21 0.009
WBC/(×109/L) 6.01±1.26 7.14±1.99 0.010
FBG/(mmol/L) 5.20±0.35 8.40±1.43 <0.001
HbA1c/% - 7.64±1.16

表2

牙周基础治疗对牙周指标、血糖及白细胞水平的影响"

Items Baseline 3 months 6 months Δ3 months Δ6 months
PD/mm
CP group 4.68±0.59 3.62±0.64* 3.47±0.57* 1.07±0.63 1.20±0.68
CP+DM group 4.63±0.95 3.61±0.60* 3.33±0.62 1.02±0.86 1.30±0.84
AL/mm
CP group 4.43±1.20 3.87±1.07* 3.58±0.81 0.56±0.66 0.85±0.66
CP+DM group 4.56±0.99 3.79±0.83* 3.76±0.86* 0.77±0.85 0.80±0.62
BI
CP group 3.20±0.63 2.09±0.61* 2.03±0.55* 1.12±0.82 1.18±0.82
CP+DM group 2.90±0.73 1.97±0.56* 1.84±0.42* 0.93±0.85 1.06±0.68
PLI
CP group 3.00±0.22 2.59±0.57* 1.85±0.75 0.41±0.52 1.15±0.73
CP+DM group 2.85±0.21# 2.42±0.58* 2.03±0.65 0.43±0.52 0.81±0.65
WBC/(×109/L)
CP group 6.01±1.26 5.35±1.37* 5.51±1.51 0.66±1.11 0.50±1.18
CP+DM group 7.14±1.99# 6.57±1.68 6.00±1.37* 0.57±2.20 1.14±1.80
FBG/(mmol/L)
CP group 5.20±0.35 5.20±0.32 5.33±0.42 0.00±0.31 -0.13±0.47
CP+DM group 8.40±1.43# 7.72±1.40# 7.35±1.14*# 0.68±1.52# 1.05±1.59#
HbA1c/%
CP group - - - - -
CP+DM group 7.64±1.16 7.09±0.79* 7.06±0.78* 0.55±0.78 0.58±0.83

表3

白细胞水平与牙周临床指标及空腹血糖水平的GLMM分析"

Parameter β SE t/Z P 95%CI
Model 1
Intercept 3.19 0.77 4.12 <0.001 1.66 to 4.71
PD 0.57 0.22 2.56 0.011 0.13 to 1.00
FBG 0.28 0.09 3.25 0.001 0.11 to 0.45
Model 2
Intercept 3.37 0.99 3.39 0.001 1.41 to 5.33
PD 0.55 0.22 2.48 0.014 0.11 to 0.99
FBG 0.27 0.09 2.98 0.003 0.09 to 0.44
Model 3
Intercept 4.10 2.34 1.75 0.082 -0.52 to 8.72
PD 0.53 0.22 2.36 0.019 0.09 to 0.96
FBG 0.29 0.09 3.33 0.001 0.12 to 0.46
Model 4
Intercept 4.73 2.47 1.91 0.058 -0.16 to 9.61
PD 0.45 0.23 1.98 0.050 0.001 to 0.90
FBG 0.26 0.09 2.94 0.004 0.09 to 0.44
[1] Graves DT, Ding Z, Yang Y. The impact of diabetes on periodontal diseases[J]. Periodontol 2000, 2020, 82(1):214-224.
doi: 10.1111/prd.12318 pmid: 31850631
[2] Genco RJ, Graziani F, Hasturk H. Effects of periodontal disease on glycemic control, complications, and incidence of diabetes mellitus[J]. Periodontol 2000, 2020, 83(1):59-65.
doi: 10.1111/prd.v83.1
[3] Costa FO, Cota LM, Lages EP, et al. Progression of periodontitis and tooth loss associated with glycemic control in individuals undergoing periodontal maintenance therapy: A 5-year follow-up study[J]. J Periodontol, 2013, 84(5):595-605.
doi: 10.1902/jop.2012.120255
[4] Mirza RE, Fang MM, Weinheimer-Haus EM, et al. Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice[J]. Diabetes, 2013, 63(3):1103-1114.
doi: 10.2337/db13-0927
[5] da Cruz GA, de Toledo S, Sallum EA, et al. Clinical and laboratory evaluations of non-surgical periodontal treatment in subjects with diabetes mellitus[J]. J Periodontol, 2008, 79(7):1150-1157.
doi: 10.1902/jop.2008.070503
[6] Correa F, Goncalves D, Figueredo C, et al. The short-term effectiveness of non-surgical treatment in reducing levels of interleukin-1beta and proteases in gingival crevicular fluid from patients with type 2 diabetes mellitus and chronic periodontitis[J]. J Periodontol, 2008, 79(11):2143-2150.
doi: 10.1902/jop.2008.080132
[7] Goncalves D, Correa F, Khalil NM, et al. The effect of non-surgical periodontal therapy on peroxidase activity in diabetic patients: A case-control pilot study[J]. J Clin Periodontol, 2010, 35(9):799-806.
doi: 10.1111/cpe.2008.35.issue-9
[8] Vozarova B, Weyer C, Lindsay RS, et al. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes[J]. Diabetes, 2002, 51(2):455-461.
pmid: 11812755
[9] Zhang H, Zhen Y, Zhang W, et al. White blood cell subtypes and risk of type 2 diabetes[J]. J Diabetes Complications, 2016, 31(1):31-37.
doi: 10.1016/j.jdiacomp.2016.10.029
[10] NibaliI L, D’Aiuto F, Griffiths G, et al. Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: A case-control study[J]. J Clin Periodontol, 2010, 34(11):931-937.
doi: 10.1111/cpe.2007.34.issue-11
[11] Wang X, Meng H, Xu L, et al. Mean platelet volume as an inflammatory marker in patients with severe periodontitis[J]. Platelets, 2015, 26(1):67-71.
doi: 10.3109/09537104.2013.875137
[12] Sonoki K, Nakashima S, Takata Y, et al. Decreased lipid peroxidation following periodontal therapy in type 2 diabetic patients[J]. J Periodontol, 2006, 77(11):1907-1913.
pmid: 17076618
[13] Navarro-Sanchez AB, Faria-Almeida R, Bascones-Martinez A. Effect of non-surgical periodontal therapy on clinical and immunological response and glycaemic control in type 2 diabetic patients with moderate periodontitis[J]. J Clin Periodontol, 2007, 34(10):835-843.
pmid: 17850602
[14] 徐菁玲, 孟焕新, 李峥, 等. 牙周基础治疗对2型糖尿病伴慢性牙周炎患者血糖代谢指标及血清生化指标的影响[J]. 北京大学学报(医学版), 2013, 45(1):27-32.
[15] Suvan J, Harrington Z, Petrie A, et al. Obesity as predictive factor of periodontal therapy clinical outcomes: A cohort study[J]. J Clin Periodontol, 2020, 47(5):594-601.
doi: 10.1111/jcpe.13261 pmid: 31994205
[16] Retamal I, Hernandez R, Velarde V, et al. Diabetes alters the involvement of myofibroblasts during periodontal wound healing[J]. Oral Dis, 2020, 26(5):1062-1071.
doi: 10.1111/odi.v26.5
[17] Trombelli L, Simonelli A, Franceschetti G, et al. What periodontal recall interval is supported by evidence?[J]. Periodontol 2000, 2020, 84(1):124-133.
doi: 10.1111/prd.12340 pmid: 32844410
[18] Mauri-Obradors E, Merlos A, Estrugo-Devesa A, et al. Benefits of non-surgical periodontal treatment in patients with type 2 diabetes mellitus and chronic periodontitis: A randomized controlled trial[J]. J Clin Periodontol, 2018, 45(3):345-353.
doi: 10.1111/jcpe.12858 pmid: 29265454
[19] Shiny A, Bibin YS, Shanthirani CS, et al. Association of neutrophil-lymphocyte ratio with glucose intolerance: An indicator of systemic inflammation in patients with type 2 diabetes[J]. Diabetes Technol Ther, 2014, 16(8):524-530.
doi: 10.1089/dia.2013.0264
[20] Cersosimo E, Defronzo RA. Insulin resistance and endothelial dysfunction: The road map to cardiovascular diseases[J]. Diabetes-Metab Res Rev, 2010, 22(6):423-436.
doi: 10.1002/(ISSN)1520-7560
[21] Tong PC, Lee KF, So WY, et al. White blood cell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetes[J]. Diabetes Care, 2004, 27(1):216-222.
doi: 10.2337/diacare.27.1.216
[22] Gao H, Xu J, He L, et al. Calprotectin levels in gingival crevicular fluid and serum of patients with chronic periodontitis and type 2 diabetes mellitus before and after initial periodontal therapy[J]. J Periodont Res, 2021, 56(1):121-130.
doi: 10.1111/jre.v56.1
[23] Gao H, Hou J, Meng H, et al. Proinflammatory effects and mecha-nisms of calprotectin on human gingival fibroblasts[J]. J Periodont Res, 2017, 52(6):975-983.
doi: 10.1111/jre.2017.52.issue-6
[1] 朱小玲,李文静,王宪娥,宋文莉,徐莉,张立,冯向辉,路瑞芳,释栋,孟焕新. 细胞色素B-245α链及胆固醇酯转运蛋白基因多态性与广泛型侵袭性牙周炎易感性的关系[J]. 北京大学学报(医学版), 2022, 54(1): 18-22.
[2] 郜洪宇,孟焕新,侯建霞,黄宝鑫,李玮. 钙结合蛋白在健康牙周组织和实验性牙周炎组织的表达分布[J]. 北京大学学报(医学版), 2021, 53(4): 744-749.
[3] 朱忆颖,闵赛南,俞光岩. 局部注射环孢素A对非肥胖糖尿病小鼠下颌下腺分泌功能及炎症的影响[J]. 北京大学学报(医学版), 2021, 53(4): 750-757.
[4] 尹雪倩, 张晓玄, 文婧, 刘思奇, 刘欣然, 周若宇, 王军波. 荞麦、燕麦、豌豆复配对糖尿病大鼠血糖的影响[J]. 北京大学学报(医学版), 2021, 53(3): 447-452.
[5] 吴俊慧,陈泓伯,武轶群,吴瑶,王紫荆,吴涛,王梦莹,王斯悦,王小文,王伽婷,于欢,胡永华. 2015—2017年北京市2型糖尿病患者骨关节炎患病的相关因素[J]. 北京大学学报(医学版), 2021, 53(3): 518-522.
[6] 郭洪萍,赵艾,薛勇,马良坤,张玉梅,王培玉. 孕期营养素摄入与妊娠期糖尿病孕妇血糖控制效果的相关性研究[J]. 北京大学学报(医学版), 2021, 53(3): 467-472.
[7] 樊理诗,高敏,Edwin B.FISHER,孙昕霙. 北京市通州区和顺义区747例2型糖尿病患者生存质量影响因素[J]. 北京大学学报(医学版), 2021, 53(3): 523-529.
[8] 陈平,黎泽明,郭怡,孙昕霙,Edwin B.FISHER. 基于大五人格理论应用潜在剖面分析探究2型糖尿病患者的用药依从性[J]. 北京大学学报(医学版), 2021, 53(3): 530-535.
[9] 刘建,王宪娥,吕达,乔敏,张立,孟焕新,徐莉,毛铭馨. 广泛型侵袭性牙周炎患者牙根形态异常与相关致病基因的关联[J]. 北京大学学报(医学版), 2021, 53(1): 16-23.
[10] 郜洪宇,徐菁玲,孟焕新,和璐,侯建霞. 牙周基础治疗对2型糖尿病伴慢性牙周炎患者红细胞、血小板相关指标的影响[J]. 北京大学学报(医学版), 2020, 52(4): 750-754.
[11] 郑鸿尘,薛恩慈,王雪珩,陈曦,王斯悦,黄辉,江锦,叶莺,黄春兰,周筠,高文静,余灿清,吕筠,吴小玲,黄小明,曹卫华,严延生,吴涛,李立明. 基于大家系设计的静息心率与常见慢性病双表型遗传度估计[J]. 北京大学学报(医学版), 2020, 52(3): 432-437.
[12] 杨航,杨林承,张瑞涛,凌云鹏,葛庆岗. 合并高血压、冠心病、糖尿病的新型冠状病毒肺炎患者发生病死的危险因素分析[J]. 北京大学学报(医学版), 2020, 52(3): 420-424.
[13] 黎泽明,高敏,陈雪莹,孙昕霙. 2型糖尿病患者大五人格特征与自我管理态度的相关性[J]. 北京大学学报(医学版), 2020, 52(3): 506-513.
[14] 闫乐,王宪娥,詹雅琳,苗莉莉,韩烨,张楚人,岳兆国,胡文杰,侯建霞. 超声龈下清创联合手工根面平整术治疗重度牙周炎的临床效果[J]. 北京大学学报(医学版), 2020, 52(1): 64-70.
[15] 张勇,刘畅,陈彬,陈帆,段晋瑜,张孟钧,焦剑. 糖尿病前期患者糖代谢异常与慢性牙周炎的相关性[J]. 北京大学学报(医学版), 2020, 52(1): 71-76.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 赵磊, 王天龙 . 右心室舒张末期容量监测用于肝移植术中容量管理的临床研究[J]. 北京大学学报(医学版), 2009, 41(2): 188 -191 .
[2] 万有, , 韩济生, John E. Pintar. 孤啡肽基因敲除小鼠电针镇痛作用增强[J]. 北京大学学报(医学版), 2009, 41(3): 376 -379 .
[3] . 书讯[J]. 北京大学学报(医学版), 2007, 39(3): 225 -328 .
[4] 常杏芝, 卢红梅, 张月华, 秦炯. 以高血压与红斑肢痛为主要表现的汞中毒一例[J]. 北京大学学报(医学版), 2007, 39(4): 377 -380 .
[5] 李西慧, 肖锋, 李岩, 杜迎利, 宋乃庆, 张明礼. 川崎病合并心肌梗死临床治疗一例[J]. 北京大学学报(医学版), 2007, 39(4): 381 -384 .
[6] 郭艳红, 李黔, 于海奕, 高炜. 增殖抑制基因诱导血管平滑肌细胞凋亡[J]. 北京大学学报(医学版), 2007, 39(4): 394 -398 .
[7] 赵会, 唐顺, 曲华毅, 郭卫, 李晓, 彭长亮. 四种不同尤文肉瘤树突状细胞免疫疫苗的体内外抗肿瘤免疫应答研究[J]. 北京大学学报(医学版), 2007, 39(4): 403 -408 .
[8] 李军, 于涛. 上消化道出血合并截瘫一例[J]. 北京大学学报(医学版), 2007, 39(4): 440 -442 .
[9] 朱燕, 赵玉亮, 卜定方, 石永进. 尿多酸肽联合丁酸钠抑制乳腺癌细胞生长的体外实验研究[J]. 北京大学学报(医学版), 2007, 39(5): 476 -480 .
[10] 黄萍, 刘炯, 夏英杰, 仲燕莹, 陈跃国. 两种准分子激光手术治疗超高度近视的对比研究[J]. 北京大学学报(医学版), 2007, 39(5): 498 -502 .